Skip to main content

Published locations for FDA revises Olysio label after adverse reactions in East Asian patients

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA revises Olysio label after adverse reactions in East Asian patients

User login

  • Reset your password
  • /content/fda-revises-olysio-label-after-adverse-reactions-east-asian-patients
  • /familypracticenews/article/107026/hepatitis/fda-revises-olysio-label-after-adverse-reactions-east
  • /ehospitalistnews/article/107026/hepatitis/fda-revises-olysio-label-after-adverse-reactions-east
  • /idpractitioner/article/107026/hepatitis/fda-revises-olysio-label-after-adverse-reactions-east-asian
  • /internalmedicinenews/article/107026/hepatitis/fda-revises-olysio-label-after-adverse-reactions-east
  • /hcvhub/article/107026/hepatitis/fda-revises-olysio-label-after-adverse-reactions-east-asian-patients
  • /infectiousdisease/article/107026/hepatitis/fda-revises-olysio-label-after-adverse-reactions-east
  • /internalmedicine/article/107026/hepatitis/fda-revises-olysio-label-after-adverse-reactions-east
  • /familymedicine/article/107026/hepatitis/fda-revises-olysio-label-after-adverse-reactions-east-asian